Epidemiology and Risk Factors of Uterine Fibroids in China
- Conditions
- Uterine Fibroid
- Registration Number
- NCT05840042
- Lead Sponsor
- Shixuan Wang
- Brief Summary
Uterine fibroids are the most common form of benign uterine tumors in the uterine muscle layer, which had a certain rate of malignancy, but it is rare. The prevalence of uterine fibroids estimates range from 4.5% to 68.6% depending on study population and diagnostic methodology. The prevalence of fibroids has been historically underestimated by epidemiologic studies which focused mainly on symptomatic women, leaving behind a large population of asymptomatic women and women who underreport their symptoms. What investigators don't know was which women who have fibroids will develop clinical symptoms and which women who have an operation of myomectomy will relapse. The purpose of this study is to investigate the prevalence, incidence and risk factors for the development of uterine fibroids in Chinese women.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 20000
- Current place of residence≥ 6 months;
- No serious mental illness or mental abnormality;
- Those who agree to participate in this survey and cooperate in completing the questionnaire.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of uterine fibroids in China Baseline Prevalence of uterine fibroids in China
- Secondary Outcome Measures
Name Time Method Risk factors of development of uterine fibroids in China Two follow-ups over a three-year period Associated risk factors for recurrence, infertility and malignancy of uterine fibroids in China
Incidence of uterine fibroids in China Two follow-ups over a three-year period Incidence of uterine fibroids in China
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.